Biological context {#Sec1}
==================

Alpha~1~-antitrypsin is a glycoprotein of the serpin (serine protease inhibitor) protein superfamily (Silverman et al. [@CR19]). It is synthesized within hepatocytes and secreted into the circulatory system, where it is the most abundant human plasma proteinase (Gooptu and Lomas [@CR9]; Travis and Salvesen [@CR20]). The primary function of α~1~-antitrypsin is the inhibition of neutrophil elastase. Naturally occurring point mutations within the protein such as the Z (Glu342Lys) variant cause it to undergo conformational rearrangement and self-associate into polymer chains (Lomas et al. [@CR11]). The accumulation of α~1~-antitrypsin polymers within the endoplasmic reticulum (ER) is associated with cellular toxicity and development of liver diseases such as cirrhosis and hepatocellular carcinoma (Eriksson et al. [@CR6]; Perlmutter [@CR14]). Polymerisation abolishes functional activity of α~1~-antitrypsin and so allows dysregulated elastase activity within the lung, causing emphysema (Elliott et al. [@CR4]). Moreover, extracellular α~1~-antitrypsin polymers are found within the lung in patients with α~1~-antitrypsin deficiency related emphysema, and are likely to have pro-inflammatory effects. The combination of loss- and gain-of-function consequences of α~1~-antitrypsin polymerisation mean there is a need for a strategy that prevents polymerisation and maintains enzyme inhibitory activity (Gooptu et al. [@CR10]). While some small molecules have shown polymerisation blocking effects in vitro, so far they have all abolished the functional activity of α~1~-antitrypsin (Mahadeva et al. [@CR12]; Mallya et al. [@CR13]). Moreover, there is a lack of structural data defining interactions of the protein with promising lead compounds, preventing their rational modification. Solution NMR is well-suited to provide a residue-specific characterisation of this conformationally heterogeneous protein and to probe its interactions with putative polymerisation blockers. We report here the ^1^H, ^15^N and ^13^C backbone assignments of 45 kDa α~1~-antitrypsin as a crucial step not only for detailed characterization of this highly dynamic molecule but also towards the application of drug discovery techniques to α~1~-antitrypsin deficiency.

Methods and experiments {#Sec2}
=======================

cDNA coding for 6xHis-tagged α~1~-antitrypsin within a pQE31 plasmid was transformed into BL21-Gold (DE3) *E. coli* (Stratagene). Cells were grown in M9 minimal medium (H~2~O or D~2~O) at 37°C with 1 g/l of ^15^NH~4~Cl (Spectra Stable Isotopes) and 2 g/l of either glucose or ^13^C-glucose (Sigma-Aldrich) as the sole nitrogen and carbon sources, respectively. Following induction of protein expression at OD~600~ = 0.6 using isopropyl β-D-1-thiogalactopyranoside (IPTG), cells were incubated at 30°C for 8 h. The cells were collected by centrifugation, resuspended in 10 mM sodium phosphate buffer, pH 8.0, 0.5 M NaCl, 20 mM imidazole, and lysed using a cell disruptor. The supernatant of the cell lysate was loaded onto a HisTrap Crude FF column (5 ml; GE Healthcare) and after washing to baseline with the same buffer, the bound protein was eluted with an imidazole gradient (20 mM -- 200 mM). The fractions containing α~1~-antitrypsin were collected, dialyzed 10 mM Tris, pH 8.0, 1 mM EDTA, and 1 mM β-mercaptoethanol and loaded onto a HiTrap-Q Sepharose column (5 ml; GE Healthcare). Bound protein was then eluted with a 0--0.5 M NaCl gradient. The fractions containing α~1~-antitrypsin were pooled, dialysed against 25 mM Na~2~HPO~4~, 50 mM NaCl and 1 mM EDTA at pH 8.0. For complete back exchange of buried backbone amides in ^2^H/^15^N/^13^C labeled α~1~-antitrypsin, the protein (1 mg/ml) was unfolded in storage buffer containing 8 M urea for 1 h at room temperature. It was subsequently refolded by dropwise addition to 5 L storage buffer with continuous stirring at 4°C. Precipitated material was removed by centrifugation, and the conformational integrity of the refolded protein was confirmed by non-denaturing and SDS-PAGE and inspection of its ^15^N TROSY-HSQC spectrum.

NMR spectra were collected from α~1~-antitrypsin at a typical concentration of 225 μM in 25 mM Na~2~HPO~4~, 50 mM NaCl, 1 mM EDTA and 0.001% 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) at pH 8.0 or pH 7.0 (10% D~2~O/90% H~2~O). Spectra from a sample prior to refolding at pH 8.0 were recorded on a Bruker Avance III 700 MHz spectrometer equipped with an HCN cryoprobe. TROSY (Pershuvin et al. [@CR15]) versions of HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB and HN(CO)CACB spectra (Eletsk et al. [@CR3]; Salzmann et al. [@CR16], [@CR17]) were acquired with constant-time chemical shift evolution in the ^15^N dimension and ^2^H decoupling (1 kHz WALTZ-16) (Shaka et al. [@CR18]) while magnetisation was transverse on CA/CB. Spectra from refolded samples at pH 8.0 and pH 7.0 were acquired on Varian Inova 600, 800 and 900 MHz spectrometers, all equipped with HCN cold-probes. TROSY-HNCA (Yang and Kay [@CR23]) spectra were acquired with ^2^H decoupling as above and constant-time chemical shift evolution in the ^13^C indirect dimension. All spectra were processed using NMRPipe (Delaglio et al. [@CR2]) and analysed using the CCPN software suite (Fogh et al. [@CR7]).

Assignments and data deposition {#Sec3}
===============================

The sequential backbone resonance assignments of α~1~-antitrypsin at pH 8.0 and pH 7.0 have been deposited in the Biological Magnetic Resonance Data Bank (<http://www.bmrb.wisc.edu>) under the accession number 17804. The ^15^N-HSQC spectrum of 45 kDa α~1~-antitrypsin shows excellent cross-peak dispersion (Fig. [1](#Fig1){ref-type="fig"}). With 394 residues, α~1~-antitrypsin is to date one of the largest proteins for which the backbone has been assigned to near completion (Supp Fig. 1). The high molecular weight rendered the backbone assignment a challenging task and this was therefore carried out in successive stages. Initially (stage 1), native ^2^H/^15^N/^13^C-labelled antitrypsin was used, followed by the use of refolded (see [Methods](#Sec2){ref-type="sec"}) ^2^H/^15^N/^13^C antitrypsin samples at pH 8.0 (stage 2) and pH 7.0 (stage 3). The majority of the secondary-structure elements were assigned in stage 1, except for resonances corresponding to the core β-sheet B and also the loop regions (Supp Fig. 2a), which were assigned during stages 2 (Supp Figs. 2b and 3a) and 3 (Supp Figs. 2c and 3b), respectively. Aside from the additional expected cross-peaks, the ^15^N-TROSY-HSQC spectra before and after refolding were identical.Fig. 1**a**^15^N-TROSY-HSQC spectrum of refolded (U-^2^H, ^15^N, ^13^C) α~1~-antitrypsin at 298 and 800 MHz. The highly overlapped central region is enlarged in (**b**)

82.8 and 79.3% of backbone amide resonances were assigned at pH 8.0 and pH 7.0, respectively. 84.9, 88.3 and 75.1% of the CO, CA and CB resonances, respectively, were assigned at pH 8.0. At pH 7.0, 82.5% of the CA resonances were assigned. The secondary structure of a1-antitrypsin was predicted from the assigned chemical shifts at pH 8.0 using DANGLE (Cheung et al. [@CR1]). The measured CA and CB chemical shifts were first corrected for deuterium isotope shifts (Venters et al. [@CR21]; Gardner et al. [@CR8]). The predicted secondary structure is broadly consistent with that observed crystallographically (Elliott et al. [@CR5]; Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Predicted secondary-structure of α1-antitrypsin. The secondary structure of the crystal structure (PDB ID 1QLP) is shown schematically and compared with the secondary structure predicted from the assigned chemical shift (CA, CB, CO and NH) using the program DANGLE (where C = random coil, H = α-helix, E = β-strand, N = no prediction). No predictions are shown for residues that are not fully assigned
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Histogram of the sizes of entries containing ^15^N assignments in the BioMagResBank (BMRB) as of July 2011. The histogram is plotted with a bin width of ten ^15^N resonances. The arrow locates the alpha1-antitrypsin assignment. The bar with asterisk represents entries with more than 350 assigned ^15^N resonances (9 entries). (TIFF 442 kb)

Residues with backbone ^1^H-^15^N assignments are highlighted in blue, not assigned are in red and prolines are in green: (a) stage 1 at pH 8.0 (b) stage 2 at pH 8.0 with refolded sample (c) stage 3 at pH 7.0. (TIFF 5217 kb)

The labelled cross peaks are the additional assignments (a) at pH 8.0 obtained after refolding the protein (b) after lowering the pH from 8.0 to 7.0. (TIFF 2903 kb)
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